Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• A systematic review of machine learning models for management, prediction and classification of ARDS1 passage
• Association between ADAM33 polymorphisms and asthma risk: a systematic review and meta-analysis1 passage
• Association between thrombocytopenia and development of acute respiratory distress syndrome1 passage
• Azithromycin and risk of COPD exacerbations in patients with and without Helicobacter pylori1 passage
• Benefits of budesonide/glycopyrronium/formoterol fumarate dihydrate on lung function and exacerbations of COPD: a post-hoc analysis of the KRONOS study by blood eosinophil level and exacerbation history1 passage
• CXCR2 antagonist for patients with chronic obstructive pulmonary disease with chronic mucus hypersecretion: a phase 2b trial1 passage
• Can roflumilast, a phosphodiesterase-4 inhibitor, improve clinical outcomes in patients with moderate-to-severe chronic obstructive pulmonary disease? A meta-analysis1 passage
• Corticosteroid plus β(2)-agonist in a single inhaler as reliever therapy in intermittent and mild asthma: a proof-of-concept systematic review and meta-analysis1 passage
• Effects of inhaled nitric oxide on ventilation/perfusion mismatch assessed by electrical impedance tomography in intubated patients with moderate-to-severe ARDS: a prospective physiological study1 passage
• Efficacy and safety of single-inhaler extrafine triple therapy versus inhaled corticosteroid plus long-acting beta2 agonist in eastern Asian patients with COPD: the TRIVERSYTI randomised controlled trial1 passage
• Fluid intake-related association between urine output and mortality in acute respiratory distress syndrome1 passage
• Genetic association and causal inference between lung function and venous thromboembolism1 passage
• Hemoadsorption in acute respiratory distress syndrome patients requiring venovenous extracorporeal membrane oxygenation: a systematic review1 passage
• InforMing the PAthway of COPD Treatment (IMPACT) trial: fibrinogen levels predict risk of moderate or severe exacerbations1 passage
• Inhaled corticosteroids and FEV(1) decline in chronic obstructive pulmonary disease: a systematic review1 passage
• Inhaled prostacyclin therapy in the acute respiratory distress syndrome: a randomized controlled multicenter trial1 passage
• Levels of immunoglobulin isotypes in serum and respiratory samples of patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis1 passage
• Monoclonal antibodies in type 2 asthma: a systematic review and network meta-analysis1 passage
• NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma1 passage
• Nebulised interferon beta-1a (SNG001) in the treatment of viral exacerbations of COPD1 passage
• Neuromuscular blocking agents for acute respiratory distress syndrome: an updated meta-analysis of randomized controlled trials1 passage
• Prognostic risk factors for moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease: a systematic literature review1 passage
• Prognostic risk prediction model for patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD): a systematic review and meta-analysis1 passage
• Risk factors for herpes zoster: should people with asthma or COPD be vaccinated?1 passage
• Safety and efficacy of corticosteroids in ARDS patients: a systematic review and meta-analysis of RCT data1 passage
• Single-inhaler triple vs single-inhaler dual therapy in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized control trials1 passage
• Step up to triple therapy versus switch to dual bronchodilator therapy in patients with COPD on an inhaled corticosteroid/long-acting β(2)-agonist: post-hoc analyses of KRONOS1 passage
• The effects of anti-inflammatory agents as host-directed adjunct treatment of tuberculosis in humans: a systematic review and meta-analysis1 passage
• Triple versus LAMA/LABA combination therapy for patients with COPD: a systematic review and meta-analysis1 passage